These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18048836)

  • 21. Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus.
    Bärnighausen T; Bloom DE; Cafiero ET; O'Brien JC
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():70-6. PubMed ID: 22882176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme].
    de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2639-40; author reply 2640-1. PubMed ID: 19105259
    [No Abstract]   [Full Text] [Related]  

  • 24. Ladies first: should boys be vaccinated against HPV?
    Leon R
    Can Fam Physician; 2008 Jul; 54(7):967-8, 972-3. PubMed ID: 18625809
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessing the HPV vaccine: researchers confront complex interplay of factors.
    Tuma RS
    J Natl Cancer Inst; 2009 Apr; 101(7):444-5. PubMed ID: 19318636
    [No Abstract]   [Full Text] [Related]  

  • 26. [How does it go on with the HPV vaccination?].
    Kaulen H
    Dtsch Med Wochenschr; 2007 Jan; 132(4):132. PubMed ID: 17338090
    [No Abstract]   [Full Text] [Related]  

  • 27. Should HPV vaccination be mandatory?
    De Soto J
    J Fam Pract; 2007 Apr; 56(4):267-8. PubMed ID: 17403324
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
    Coupé VM; Meijer CJ; Berkhof J
    J Natl Cancer Inst; 2010 Mar; 102(5):358; author reply 358. PubMed ID: 19861306
    [No Abstract]   [Full Text] [Related]  

  • 29. Broad-spectrum human papillomavirus vaccines: new horizons but one step at a time.
    Bosch FX
    J Natl Cancer Inst; 2009 Jun; 101(11):771-3. PubMed ID: 19470950
    [No Abstract]   [Full Text] [Related]  

  • 30. Prophylactic human papillomavirus vaccination: a breakthrough in primary cervical cancer prevention.
    Garcia FA; Saslow D
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):761-81, ix. PubMed ID: 18061868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy.
    Kim JJ; Kobus KE; Diaz M; O'Shea M; Van Minh H; Goldie SJ
    Vaccine; 2008 Jul; 26(32):4015-24. PubMed ID: 18602731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Providing vaccines against human papillomavirus to adolescent girls in the Americas: battling cervical cancer, improving overall health.
    Luciani S; Prieto-Lara E; Vicari A
    Health Aff (Millwood); 2011 Jun; 30(6):1089-95. PubMed ID: 21653962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of cervical cancer. Screening and vaccination: methods of use].
    Boulanger JC
    Gynecol Obstet Fertil; 2011; 39(7-8):405-6. PubMed ID: 21757389
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of cervical cancer in Central and Eastern Europe and Central Asia: a challenge for the future.
    Kesic V
    Vaccine; 2013 Dec; 31 Suppl 7():vii-ix. PubMed ID: 24332301
    [No Abstract]   [Full Text] [Related]  

  • 35. No Vacillation on HPV Vaccination.
    Sipp D; Frazer IH; Rasko JEJ
    Cell; 2018 Mar; 172(6):1163-1167. PubMed ID: 29522737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands.
    Coupé VM; de Melker HE; Snijders PJ; Meijer CJ; Berkhof J
    Vaccine; 2009 Aug; 27(37):5111-9. PubMed ID: 19567242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus vaccine.
    Suba EJ; Raab SS;
    N Engl J Med; 2007 Sep; 357(11):1155; author reply 1155-6. PubMed ID: 17874469
    [No Abstract]   [Full Text] [Related]  

  • 38. Human papillomavirus vaccine--opportunity and challenge.
    Baden LR; Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2007 May; 356(19):1990-1. PubMed ID: 17494932
    [No Abstract]   [Full Text] [Related]  

  • 39. Age considerations when vaccinating against HPV.
    Wright TC; Huh WK; Monk BJ; Smith JS; Ault K; Herzog TJ
    Gynecol Oncol; 2008 May; 109(2 Suppl):S40-7. PubMed ID: 18482558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Q&A: On the case. Interview by Michelle Grayson.
    zur Hausen H
    Nature; 2012 Aug; 488(7413):S16. PubMed ID: 22932436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.